These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27365760)

  • 21. [Prognostic Value of Morphology and Hans Classification in Diffuse Large B Cell Lymphoma].
    Wang KL; Chen C; Shi PF; Yu JH; Tan JF; Qian SX; Gao DQ; Chen K; Liu LR; Xie YP; Xu Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1079-1085. PubMed ID: 30111411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
    Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
    J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients.
    Liu YH; Xu FP; Zhuang HG; Lai KC; Xie D; Luo DL; Li L; Luo XL; Xu J; Zhang MH; Zhang F; Li HM
    Hum Pathol; 2008 Jun; 39(6):875-84. PubMed ID: 18440593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of CD68, cyclin D1 and rearrangement of bcl-6 gene are adverse prognostic factors in diffuse large B-cell lymphoma].
    Liang X; Wang J; Bai W; Sun R
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):559-64. PubMed ID: 26705179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of immunohistochemical subtypes in diffuse large B-cell lymphoma and its impact on survival.
    Dwivedi A; Mehta A; Solanki P
    Indian J Pathol Microbiol; 2015; 58(4):453-8. PubMed ID: 26549066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples.
    Cozzolino I; Varone V; Picardi M; Baldi C; Memoli D; Ciancia G; Selleri C; De Rosa G; Vetrani A; Zeppa P
    Cancer Cytopathol; 2016 Feb; 124(2):135-43. PubMed ID: 26414904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical subtyping of diffuse large B-cell lymphoma into germinal center B-cell and activated B-cell subtype, along with correlation of the subtypes with extranodal involvement, serum lactate dehydrogenase, and positron emission tomography scan-based response assessment to chemotherapy.
    Tyagi A; Abrari A; Khurana A; Tyagi S
    J Cancer Res Ther; 2022; 18(4):1129-1136. PubMed ID: 36149172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological features of primary central nervous system diffuse large B cell lymphoma: Experience from a Tertiary Center in North India.
    Radotra BD; Parkhi M; Chatterjee D; Yadav BS; Ballari NR; Prakash G; Gupta SK
    Surg Neurol Int; 2020; 11():424. PubMed ID: 33365186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Cell-Origin Profiling Using Immunohistochemistry to Predict the Survival of Patients with Diffuse Large B-Cell Lymphoma in Indonesia.
    Istiadi H; Sadhana U; Puspasari D; Miranti IP; Karlowee V; Listiana DE; Prasetyo A
    Yonago Acta Med; 2021 May; 64(2):200-206. PubMed ID: 34025195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue microarray in a subset of South African patients with DLBCL.
    Sissolak G; Wood L; Smith L; Chan JW; Armitage J; Jacobs P
    Transfus Apher Sci; 2013 Oct; 49(2):120-32. PubMed ID: 23942329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD30-Positive Anaplastic Variant of Diffuse Large B-cell Lymphoma: Frequency and Association With Clinicopathological Parameters.
    Hashmi AA; Haider R; Nargus G; Ahmed O; Yaqeen SR; Asghar IA; Afzal A; Irfan M; Edhi MM; Ali J
    Cureus; 2021 Feb; 13(2):e13209. PubMed ID: 33717748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas.
    De Paepe P; Achten R; Verhoef G; Wlodarska I; Stul M; Vanhentenrijk V; Praet M; De Wolf-Peeters C
    J Clin Oncol; 2005 Oct; 23(28):7060-8. PubMed ID: 16129841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic subgroup distribution in diffuse large B-cell lymphoma of the upper aerodigestive tract.
    Wong KK; Prepageran N; Peh SC
    Pathology; 2009 Feb; 41(2):133-9. PubMed ID: 18972319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of diffuse large B-cell lymphoma of germinal center B-cell origin in whole diffuse large B-cell lymphoma: tissue fluorescence in situ hybridization using t(14;18) compared with immunohistochemistry.
    Hirose Y; Masaki Y; Karasawa H; Shimoyama K; Fukushima T; Kawabata H; Ogawa N; Wano Y; Ozaki M
    Int J Hematol; 2005 Jan; 81(1):48-57. PubMed ID: 15717689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Potential mechanism and prognostic value of promoter methylation of PRDM1 gene in diffuse large B cell lymphoma].
    Zhang XY; Ma ZP; Cui WL; Chen R; Glinaer A; Miao N; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):831-837. PubMed ID: 28056297
    [No Abstract]   [Full Text] [Related]  

  • 36. Biological characterization of nodal versus extranodal presentation of diffuse large B-Cell lymphoma using immunohistochemistry.
    Kim MK; Bae SH; Bae YK; Kum YS; Ryoo HM; Cho HS; Lee KH; Koh SA; Lee HY; Yun SY; Choi JH; Hyun MS
    Clin Lymphoma Myeloma Leuk; 2011 Oct; 11(5):403-8. PubMed ID: 21700526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue microarrays in diffuse large B-cell lymphomas: are they really able to identify distinct prognostic groups in lymphomas of both nodal and extranodal origin?
    Laszlo D; Pruneri G; Andreola G; Radice D; Calabrese L; Rafaniello PR; Nassi L; Sammassimo S; Alietti A; Agazzi A; Vanazzi A; Martinelli G
    Int J Surg Pathol; 2011 Aug; 19(4):417-24. PubMed ID: 19793830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of programmed cell death ligand-1 protein in germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
    Asrini R; Ham MF; Asmarinah A; Harahap AS; Hardjolukito ESR
    Mol Clin Oncol; 2022 Feb; 16(2):42. PubMed ID: 35003740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse Large B Cell Lymphoma: Immunohistochemical Classification According to Hans Algorithm and Association With Outcome in A Moroccan Institution.
    Taybi M; Bourkhime H; Khammar Z; Alami Drideb N; Berrady R; Benmiloud S; Elfakir S; Bouguenouch L; Tahiri L; Chbani L; Hammas N
    Clin Pathol; 2024; 17():2632010X241289778. PubMed ID: 39398500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.
    Chang CC; McClintock S; Cleveland RP; Trzpuc T; Vesole DH; Logan B; Kajdacsy-Balla A; Perkins SL
    Am J Surg Pathol; 2004 Apr; 28(4):464-70. PubMed ID: 15087665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.